← Leaderboards
Volney L Sheen
Beth Israel Deaconess Medical Center
$6,719,716
Attributed
$7,638,192
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,638,192 · 6
By mechanism
R01$5,551,495 · 3
R21$1,230,698 · 2
K08$855,999 · 1
Top collaborators
- Russell James Ferland5 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Yuanyi Feng$4,229,879
- Christopher A Walsh$66,138,888
- Bernard S. Chang$2,731,869
- Russell James Ferland$3,197,792
- John Louis Rinn$12,414,206
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesProteinsPhenotypeBrainDefectProgenitorNerve Stem CellNeuronsCellsLeadRelating To Nervous SystemTherapeutic InterventionSeizuresImpairmentSignal TransductionPathway InteractionsCell DeathMental RetardationGene ExpressionMediatingMolecularMouse ModelEpilepsyGene Mutation
Grant awards (22)
Down Syndrome: a potential treatment XISTs$564,755
R01 · FY2025 · HD · contact PI
Down Syndrome: a potential treatment XISTs$1,693,316
R01 · FY2022 · HD · contact PI
Deciphering HSA21 genes associated with Alzheimers disease in Down Syndrome$281,948
R21 · FY2020 · NS · contact PI
Epigenetic Silencing of HSA21 in Down Syndrome$262,500
R21 · FY2020 · NS · contact PI
Apical Abscission and Periventricular Heterotopia: A common basis for disease$363,126
R01 · FY2019 · NS · contact PI
Epigenetic Silencing of HSA21 in Down Syndrome$218,750
R21 · FY2019 · NS · contact PI
Apical Abscission and Periventricular Heterotopia: A common basis for disease$363,126
R01 · FY2018 · NS · contact PI
Apical Abscission and Periventricular Heterotopia: A common basis for disease$363,126
R01 · FY2017 · NS · contact PI
Apical Abscission and Periventricular Heterotopia: A common basis for disease$363,126
R01 · FY2016 · NS · contact PI
Apical Abscission and Periventricular Heterotopia: A common basis for disease$384,448
R01 · FY2015 · NS · contact PI
Cellular and Molecular Mechanisms in Periventricular Heterotopia$281,347
R01 · FY2013 · NS · contact PI
Cellular and Molecular Mechanisms in Periventricular Heterotopia$291,550
R01 · FY2012 · NS · contact PI
Cellular and Molecular Mechanisms in Periventricular Heterotopia$291,550
R01 · FY2011 · NS · contact PI
Cellular and Molecular Mechanisms in Periventricular Heterotopia$294,525
R01 · FY2010 · NS · contact PI
Cellular and Molecular Mechanisms in Periventricular Heterotopia$297,500
R01 · FY2009 · NS · contact PI
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome$255,000
R21 · FY2009 · HD · contact PI
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome$212,500
R21 · FY2008 · HD · contact PI
The Role of Filamin in Periventricular Heterotopias$171,515
K08 · FY2005 · MH
The Role of Filamin in Periventricular Heterotopias$171,515
K08 · FY2004 · MH
The Role of Filamin in Periventricular Heterotopias$171,515
K08 · FY2003 · MH
The Role of Filamin in Periventricular Heterotopias$171,515
K08 · FY2002 · MH
The Role of Filamin in Periventricular Heterotopias$169,939
K08 · FY2001 · MH